Nuvation Bio Inc. financial data

Symbol
NUVB, NUVB-WT on NYSE
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 03 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 897% % -47%
Quick Ratio 2.6% %
Debt-to-equity 44% % 419%
Return On Equity -55% % 49%
Return On Assets -38% % 57%
Operating Margin -871% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 342,833,433 shares 1.9%
Common Stock, Shares, Outstanding 337,837,872 shares 0.47%
Entity Public Float $522,742,050,000 USD 100%
Common Stock, Value, Issued $1,404,799,000 USD 3.1%
Weighted Average Number of Shares Outstanding, Basic 342,393 shares 25%
Weighted Average Number of Shares Outstanding, Diluted 342,393 shares 25%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $13,120,000 USD 1705%
Revenue from Contract with Customer, Excluding Assessed Tax $26,748,000 USD 1705%
Research and Development Expense $110,108,000 USD 29%
General and Administrative Expense $28,156,000 USD -13%
Operating Income (Loss) $232,969,000 USD 58%
Nonoperating Income (Expense) $15,489,000 USD -43%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $217,480,000 USD 59%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $217,480,000 USD 59%
Earnings Per Share, Basic 0 USD/shares 78%
Earnings Per Share, Diluted 0 USD/shares 78%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $98,897,000 USD 229%
Marketable Securities, Current $450,148,000 USD -13%
Inventory, Net $5,710,000 USD
Assets, Current $577,530,000 USD 2.2%
Property, Plant and Equipment, Net $560,000 USD -22%
Operating Lease, Right-of-Use Asset $4,329,000 USD 75%
Other Assets, Noncurrent $7,462,000 USD 1455%
Assets $601,561,000 USD 5.2%
Accounts Payable, Current $15,360,000 USD 24%
Accrued Liabilities, Current $32,579,000 USD 39%
Contract with Customer, Liability, Current $6,721,000 USD -48%
Liabilities, Current $68,131,000 USD 15%
Contract with Customer, Liability, Noncurrent $13,614,000 USD
Accrued Income Taxes, Noncurrent $679,000 USD 372%
Operating Lease, Liability, Noncurrent $2,970,000 USD 202%
Liabilities $275,679,000 USD 300%
Common Stocks, Including Additional Paid in Capital $116,986,000 USD
Accumulated Other Comprehensive Income (Loss), Net of Tax $139,000 USD -110%
Retained Earnings (Accumulated Deficit) $1,078,778,000 USD -25%
Stockholders' Equity Attributable to Parent $325,882,000 USD -35%
Liabilities and Equity $601,561,000 USD 5.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $42,627,000 USD -171%
Net Cash Provided by (Used in) Financing Activities $548,000 USD 2510%
Net Cash Provided by (Used in) Investing Activities $54,182,000 USD 618%
Common Stock, Shares Authorized 1,060,000,000 shares
Common Stock, Shares, Issued 342,756,387 shares 1.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $12,254,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $98,897,000 USD 229%
Deferred Tax Assets, Valuation Allowance $238,145,000 USD 137%
Deferred Tax Assets, Gross $242,589,000 USD 139%
Operating Lease, Liability $4,841,000 USD 75%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $218,999,000 USD 58%
Lessee, Operating Lease, Liability, to be Paid $5,497,000 USD 88%
Property, Plant and Equipment, Gross $1,460,000 USD 5.6%
Operating Lease, Liability, Current $1,871,000 USD 5.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,184,000 USD 46%
Lessee, Operating Lease, Liability, to be Paid, Year One $533,000 USD -6.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 402%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $656,000 USD 313%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,404,000 USD 97%
Deferred Tax Assets, Operating Loss Carryforwards $107,698,000 USD 268%
Unrecognized Tax Benefits $7,391,000 USD 31%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,216,000 USD 744%
Share-based Payment Arrangement, Expense $38,095,000 USD 48%
Interest Expense $5,121,000 USD